281 - 290 of 6255 Results
Title
Year
- Longitudinal Analysis of Brain-Predicted Age in Amnestic and Non-amnestic Sporadic Early-Onset Alzheimer's Disease2021OPENTitle: Longitudinal Analysis of Brain-Predicted Age in Amnestic and Non-amnestic Sporadic Early-Onset Alzheimer's DiseaseJournal Name: Frontiers in Aging NeurosciencePublisher: Frontiers Media SAVol: 13Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnagi.2021.729635Best OA location URL: https://doi.org/10.3389/fnagi.2021.729635Citation Count: 15
- Development and Validation of a Prognostic Model for Cognitive Impairment in Parkinson’s Disease With REM Sleep Behavior Disorder2021OPENTitle: Development and Validation of a Prognostic Model for Cognitive Impairment in Parkinson’s Disease With REM Sleep Behavior DisorderJournal Name: Frontiers in Aging NeurosciencePublisher: Frontiers Media SAVol: 13Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnagi.2021.703158Best OA location URL: https://www.frontiersin.org/articles/10.3389/fnagi.2021.703158/pdfCitation Count: 8
-
OPENTitle: Automatic Speech Recognition in Noise for Parkinson's Disease: A Pilot StudyJournal Name: Frontiers in Artificial IntelligencePublisher: Frontiers Media SAVol: 4Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/frai.2021.809321Best OA location URL: https://www.frontiersin.org/articles/10.3389/frai.2021.809321/pdfCitation Count: 10
- Trajectory Analysis of Orthostatic Hypotension in Parkinson’s Disease: Results From Parkinson’s Progression Markers Initiative Cohort2021OPENTitle: Trajectory Analysis of Orthostatic Hypotension in Parkinson’s Disease: Results From Parkinson’s Progression Markers Initiative CohortJournal Name: Frontiers in Aging NeurosciencePublisher: Frontiers Media SAVol: 13Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnagi.2021.762759Best OA location URL: https://www.frontiersin.org/articles/10.3389/fnagi.2021.762759/pdfCitation Count: 6
- Identification of Novel Single-Nucleotide Variants With Potential of Mediating Malfunction of MicroRNA in Congenital Heart Disease2021OPENTitle: Identification of Novel Single-Nucleotide Variants With Potential of Mediating Malfunction of MicroRNA in Congenital Heart DiseaseJournal Name: Frontiers in Cardiovascular MedicinePublisher: Frontiers Media SAVol: 8Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fcvm.2021.739598Best OA location URL: https://doi.org/10.3389/fcvm.2021.739598Citation Count: 3
-
OPENTitle: Mitochondrial Defects in Fibroblasts of Pathogenic MAPT PatientsJournal Name: Frontiers in Cell and Developmental BiologyPublisher: Frontiers Media SAVol: 9Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fcell.2021.765408Best OA location URL: https://doi.org/10.3389/fcell.2021.765408Citation Count: 5
-
OPENTitle: Assessing the Quality and Reliability of COVID-19 Information on Patient Organization WebsitesJournal Name: Frontiers in CommunicationPublisher: Frontiers Media SAVol: 6Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fcomm.2021.716683Best OA location URL: https://www.frontiersin.org/journals/communication/articles/10.3389/fcomm.2021.716683/pdfCitation Count: 8
-
OPENTitle: Genetic control of the human brain proteomeJournal Name: The American Journal of Human GeneticsPublisher: Elsevier BVVol: 108Issue #: 3Start Page: 400End Page: 410Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.ajhg.2021.01.012Best OA location URL: http://www.cell.com/article/S0002929721000124/pdfCitation Count: 86
-
OPENTitle: Stability Evaluation of Brain Changes in Parkinson's Disease Based on Machine LearningJournal Name: Frontiers in Computational NeurosciencePublisher: Frontiers Media SAVol: 15Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fncom.2021.735991Best OA location URL: https://doi.org/10.3389/fncom.2021.735991Citation Count: 9
- Safety and efficacy of tilavonemab in progressive supranuclear palsy: a phase 2, randomised, placebo-controlled trial2021OPENTitle: Safety and efficacy of tilavonemab in progressive supranuclear palsy: a phase 2, randomised, placebo-controlled trialJournal Name: The Lancet NeurologyPublisher: Elsevier BVVol: 20Issue #: 3Start Page: 182End Page: 192Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/s1474-4422(20)30489-0Best OA location URL: http://www.thelancet.com/article/S1474442220304890/pdfCitation Count: 113